Class information for:
Level 1: PRANLUKAST//MONTELUKAST//CYSTEINYL LEUKOTRIENES

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
966 2840 37.0 71%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
860 10928 5 LIPOXYGENASE//EXPT THER EUT REPERFUS INJURY//LEUKOTRIENES

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PRANLUKAST Author keyword 52 60% 2% 56
2 MONTELUKAST Author keyword 48 27% 5% 156
3 CYSTEINYL LEUKOTRIENES Author keyword 36 35% 3% 84
4 ZAFIRLUKAST Author keyword 35 49% 2% 53
5 LEUKOTRIENE RECEPTOR ANTAGONIST Author keyword 33 39% 2% 67
6 CYSLT1 RECEPTOR Author keyword 32 88% 1% 15
7 CYSTEINYL LEUKOTRIENE RECEPTOR Author keyword 28 81% 1% 17
8 CYSTEINYL LEUKOTRIENE Author keyword 24 46% 1% 39
9 BAY U9773 Author keyword 23 100% 0% 10
10 CYSLT1 Author keyword 19 80% 0% 12

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PRANLUKAST 52 60% 2% 56 Search PRANLUKAST Search PRANLUKAST
2 MONTELUKAST 48 27% 5% 156 Search MONTELUKAST Search MONTELUKAST
3 CYSTEINYL LEUKOTRIENES 36 35% 3% 84 Search CYSTEINYL+LEUKOTRIENES Search CYSTEINYL+LEUKOTRIENES
4 ZAFIRLUKAST 35 49% 2% 53 Search ZAFIRLUKAST Search ZAFIRLUKAST
5 LEUKOTRIENE RECEPTOR ANTAGONIST 33 39% 2% 67 Search LEUKOTRIENE+RECEPTOR+ANTAGONIST Search LEUKOTRIENE+RECEPTOR+ANTAGONIST
6 CYSLT1 RECEPTOR 32 88% 1% 15 Search CYSLT1+RECEPTOR Search CYSLT1+RECEPTOR
7 CYSTEINYL LEUKOTRIENE RECEPTOR 28 81% 1% 17 Search CYSTEINYL+LEUKOTRIENE+RECEPTOR Search CYSTEINYL+LEUKOTRIENE+RECEPTOR
8 CYSTEINYL LEUKOTRIENE 24 46% 1% 39 Search CYSTEINYL+LEUKOTRIENE Search CYSTEINYL+LEUKOTRIENE
9 BAY U9773 23 100% 0% 10 Search BAY+U9773 Search BAY+U9773
10 CYSLT1 19 80% 0% 12 Search CYSLT1 Search CYSLT1

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ICI 204 219 90 82% 2% 53
2 CYSLT2 RECEPTOR 62 92% 1% 24
3 CYSLT1 RECEPTOR 61 70% 2% 51
4 LEUKOTRIENE RECEPTOR ANTAGONIST 47 29% 5% 138
5 CYSTEINYL LEUKOTRIENES 47 28% 5% 143
6 ALLERGEN INDUCED BRONCHOCONSTRICTION 47 61% 2% 50
7 INHALED LEUKOTRIENE D4 40 79% 1% 26
8 HUMAN INTRALOBAR AIRWAYS 37 81% 1% 22
9 PEPTIDE LEUKOTRIENES 36 63% 1% 36
10 URINARY LEUKOTRIENE E4 36 44% 2% 62

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Cysteinyl leukotriene receptors, old and new; implications for asthma 2012 30 62 68%
Treatment of asthma with drugs modifying the leukotriene pathway 1999 496 98 52%
Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional Characteristics 2010 59 120 66%
Cysteinyl leukotrienes and their receptors: (Cellular distribution and function in immune and inflammatory responses 2004 168 81 58%
Stepping down from inhaled corticosteroids with leukotriene inhibitors in asthma: A systematic review and meta-analysis 2015 2 10 50%
International union of pharmacology - XXXVII. Nomenclature for leukotriene and lipoxin receptors 2003 170 347 59%
A review on leukotrienes and their receptors with reference to asthma 2013 10 102 67%
Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts 2014 9 82 44%
Cysteinyl leukotrienes in allergic inflammation - Strategic target for therapy 2005 80 103 62%
Treatment of asthma with antileukotrienes: First line or last resort therapy? 2006 76 170 56%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 SECT EICOSANOID PHARMACOL 8 75% 0.2% 6
2 HUNTERIAN PHARMACOL 3 100% 0.1% 3
3 PULM IMMUNOL 3 26% 0.3% 9
4 MED MC6076 2 50% 0.1% 3
5 ESA 8078 2 23% 0.2% 7
6 CARDIOPULM PHARMACOL 1 19% 0.2% 6
7 CELL EXPT PATHOL 1 30% 0.1% 3
8 HANGZHOU NEUROBIOL 1 40% 0.1% 2
9 LSCPA EA2937 1 40% 0.1% 2
10 INTERDISCIPLINARY INDIAN SYST MED 1 25% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000189863 LIPOPHILIC MOIETY//3 HEXENOL//BIOCARTOL
2 0.0000180748 5 LIPOXYGENASE//LEUKOTRIENE A4 HYDROLASE//5 LIPOXYGENASE ACTIVATING PROTEIN
3 0.0000174518 5 OXO ETE//CLAUDE PEPPER//5 HETE
4 0.0000087031 ASPIRIN EXACERBATED RESPIRATORY DISEASE//ASPIRIN INDUCED ASTHMA//ASPIRIN DESENSITIZATION
5 0.0000075321 EPITHELIUM DERIVED RELAXING FACTOR//COAXIAL BIOASSAY//EPITHELIUM DERIVED INHIBITORY FACTOR EPDIF
6 0.0000072046 EOSINOPHIL CATIONIC PROTEIN//EOSINOPHIL PROTEIN X//LATE ASTHMATIC RESPONSE
7 0.0000061711 CA2 UNDERSHOOT//PHYSIOL CELLULAIRE P//PHORBOL 12 13 DIACETATE
8 0.0000059511 IBUDILAST//CAS 50847 11 5//221 MIYAMA
9 0.0000056558 AZELASTINE//ALLERGODILR//CAS 58581 89 8
10 0.0000050748 LEUKOTRIENE C 4 SYNTHESIS DEFICIENCY//HADASSAH MED PHARMACOL//EICOSATETRAYNOIC ACID